State of Tennessee, Treasury Department »

BioMarin Pharmaceutical shares owned by State of Tennessee, Treasury Department

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by State of Tennessee, Treasury Department from 13F filings

Historical chart of State of Tennessee, Treasury Department investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by State of Tennessee, Treasury Department consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by State of Tennessee, Treasury Department

Quarter filed Position value Share count Share price at filing
2024-06-30 $6.1M 74k 82.33
2016-09-30 $1.7M 18k 92.54
2015-03-31 $13M 101k 124.62

More positions owned by State of Tennessee, Treasury Department

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corporation Common Stock (NVDA)
Ishares Inc Msci Taiwan Etf Exchange Traded Product (EWT)
Amazon Common Stock (AMZN)
Vanguard Index Fds Total Stk Mkt Exchange Traded Product (VTI)
Ishares Tr Msci India Etf Exchange Traded Product (INDA)
Ishares Inc Msci Sth Kor Etf Exchange Traded Product (EWY)
Meta Platforms Inc Cl A Common Stock (META)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Vanguard Scottsdale Fds Int-term Corp Exchange Traded Product (VCIT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt Exchange Traded Product (VEA)
Ishares Tr Mbs Etf Exchange Traded Product (MBB)
Vanguard Scottsdale Fds Lg-term Cor Bd Exchange Traded Product (VCLT)

View all positions for State of Tennessee, Treasury Department

Top funds holding BioMarin Pharmaceutical

BlackRock
BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
Capital Research Global Investors
Viking Global Investors
State Street Corporation
Elliott Investment Management
Geode Capital Management
Jpmorgan Chase & Co
Bank of New York Mellon
Citadel Advisors
Deutsche Bank Aktiengesellschaft
Northern Trust

View all funds holding BioMarin Pharmaceutical